Recognizing and managing depression in women throughout the stages of life

Cleveland Clinic Journal of Medicine

Volumn 67, Issue 5, 2000, Pages 329-338

  Carandang, Jennifer M ^b   Franco Bronson, Kathleen ^a   Kamarei, Shaparak ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; ANXIOLYTIC AGENT; BUSPIRONE; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; NORTRIPTYLINE; ORAL CONTRACEPTIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

DEPRESSION; DIET; DRUG EXCRETION; DYSPHORIA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; PSYCHOTHERAPY; PUERPERAL DEPRESSION; REVIEW; RISK FACTOR; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; VITAMIN SUPPLEMENTATION;

EID: 0034025514     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.67.5.329     Document Type: Review

References (51)

1. Weissmen MM, Bland R, Joyce PR, Newman S, Wells JE, Wittchen HV. Sex differences in rates of depression: cross-national perspectives. J Affect Disord 1993; 29:77-84.
2. Kessler RC, McGonagle KA, Swartz M, et al. Sex and depression in the national comorbidity survey, I: lifetime prevalence, chronicity, and recurrence. J Affect Disord 1993; 29:85-96.
3. Kroenke K, Spitzer RL. Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med 1998; 60:150-155.
4. Greenberg PE, Stiglin LE, Finkelstein SN, Benndt ER. The economic burden of depression in 1990. J Clin Psychiatry 1993; 54:405-418.
5. Leibenluft E, Hardin TA, Rosenthal NE. Gender differences in seasonal affective disorder. Depression 1995; 3:13-19.
6. Keitner GI, Ryan CE, Miller IW, et al. 12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression). Am J Psychiatry 1991; 148:345-350.
7. Canetto SS, Sakinofsky I. The gender paradox in suicide. Suicide Life Threat Behav 1998; 28(1):1-23.
8. Kornstein S. Gender differences in depression: implications for treatment. J Clin Psychiatry 1997; 58(suppl 15):12-18.
9. Kaplan HI, Sadock BJ. Comprehensive textbook of psychiatry. 6th ed. Baltimore: Williams and Wilkins; 1995:1547.
10. Johnson SR. The epidemiology and social impact of premenstrual symptoms. Clin Obstet Gynecol 1987; 30:367-376.
11. Muzina KS, Gonsalves L. Commonly asked questions about premenstrual dysphoric disorder. Cleve Clin J Med 1998; 65:142-149.
12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994:715-718.
13. Yonkers K, Halbreich U, Freemand E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. JAMA 1977; 278:983-988.
14. Rapkin A. The role of serotonin in premenstrual syndrome. Clin Obstet Gynecol 1992; 35:629-636.
15. Stone AB, Pearlstein TB, Brown WA. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1991; 52:290-293.
16. Freeman EW, Rickel K, Sonheimer SJ, Polansky M. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 1995; 274:51-57.
17. Harrison WM, Endicott J, Nee J. Treatment of premenstrual dysphoria with alprazolam: a controlled study. Arch Gen Psychiatry 1990; 47:270-275.
18. Smith S, Rinehart JS, Ruddock VE, Schiff I. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial. Obstet Gynecol 1987; 70:37-43.
19. Rickels K, Freeman E, Sondheimer S. Buspirone in treatment of premenstrual syndrome [letter]. Lancet 1989; 4:777.
20. Parry BL. Reproductive factors affecting the course of affective illness in women. Psychiatr Clin North Am 1989; 12:207-220.
21. Cohen LS, Rosenbaum JF. Hormonal therapies for psychiatric symptoms in women: possibilities and cautions. Harv Rev Psychiatry 1994; 1:353-355.
22. Deijen JB, Duyn KJ, Jansen WA, et al. Use of a monophasic, lowdose oral contraceptive in relation to mental functioning. Contraception 1992; 46:359-367.
23. Abernethy DR, Greenblatt DJ, Shader RI. Imipramine disposition in users of oral contraceptives. Clin Pharmacol Ther 1984; 35:792-797.
24. Susman JL. Postpartum depressive disorders. J Fam Pract 1996; 43:633-639.
25. Pariser SF, Nasrallah HA, Gardner DK. Postpartum mood disorders: clinical perspectives. J Womens Health 1997; 6:421-434.
26. Wisner KL, Wheeler SB. Prevention of recurrent postpartum major depression. Hosp Community Psychiatry 1994; 45:1191-1196.
27. Harris B, Othman S, Davies JA, et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ 1992; 305:152-156.
28. Kendel RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987; 150:662-673.
29. Seidman D. Postpartum psychiatric illness: the role of the pediatrician. Pediatrics 1998; 19:128-131.
30. Stein A, Gath DH, Butcher J, et al. The relationship between postnatal depression and mother child interaction. Br J Psychiatry 1991; 158:46-52.
31. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. Am J Psychiatry 1996; 153:1132-1137.
32. Halbreich U. Role of estrogen in postmenopausal depression. Neurology 1997; 48 Suppl 7:516-520.
33. Arpels JC. The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause: a hypothesis and review of supporting data. J Reprod Med 1996; 41:633-639.
34. Pearce J, Hawton K, Blake F. Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. BMJ 1995; 167:163-173.
35. Dampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 1994; 83:979-983.
36. Phillips SM, Sherwin BB. Effects of estrogen on memory function n surgically menopausal women. Psychoneuroendocrinology 1992; 17:485-495.
37. Stahl SM. Sex therapy in psychiatric treatment has a new partner: reproductive hormones. J Clin Psychiatry 1997; 58:468-469.
38. Lopez-Jaramillo P, Teran E, Molina G, et al. Oestrogens and depression. Lancet 1996; 348:135-136.
39. Bech P, Munk-Jensen N, Obel EB, et al. Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life related outcome measures. Psychother Psychosom 1998; 67:259-265.
40. Cobbs EL, Ralapati AN. Health of older women. Med Clin North Am 1998; 82:127-136.
41. Zeiss AM, Lewinsohn PM, Rohde P, Seeley JR. Relationship of physical disease and functional impairment to depression in older people. Psychol Aging 1996; 11:572-581.
42. Forsell Y, Jorm AF, Fratiglioni L, Grut M, Winblad B. Application of DSM-IIIR criteria for major depressive episode to elderly subjects with and without dementia. Am J Psychiatry 1993; 150:1199-1202.
43. Melden SW, Emerman CL, Schubert DSP, et al. Depression in geriatric ED patients: prevalence and recognition. Ann Emer Med 1997; 30:141-145.
44. Wattis J. What an old age psychiatrist does. BMJ 1996; 313:101-104.
45. Busse EW, Blazer DG. The American Psychiatric Pressbook of geriatric psychiatry. 2nd ed. Washington, DC: American Psychiatric Press; 1996:246.
46. Alarcon FJ, Isaacson JH, Franco-Bronson K. Diagnosing and treating depression in primary care patients: looking beyond physical complaints. Cleve Clin J Med 1998; 65:251-260.
47. Lebowitz BD, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late life. JAMA 1997; 278:1186-1190.
48. Flint AJ, Rifat SL. Recurrence of first-episode depression after discontinuation of maintenance antidepressants. Am J Psychiatry 1999; 156:943-945.
49. Lavretsky H. Late-life depression: risk factors, treatment, and sex differences. Clinical Geriatrics 1998; 6(3):13-24.
50. Greden JF. Antidepressant maintenance medications: when to discontinue and how to stop. J Clin Psychiatry 1993; 54(suppl 8):39-45.
51. Doll H, Brown S, Thurston A, Vessey M. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial. J Royal Coll Gen Pract 1989; 9:364-368.